Key result
Transapical TEER reduces LVOT gradients by ~83% and resolves SAM in preliminary experience.
Why the study?
Transapical mitral valve edge-to-edge repair offers a therapeutic option for obstructive hypertrophic cardiomyopathy with severe mitral regurgitation and systolic anterior motion, but clinical experience in patients declining surgery is limited.
Does transapical transcatheter edge-to-edge repair (TA-TEER) improve left ventricular outflow tract gradients and mitral regurgitation in patients with obstructive hypertrophic cardiomyopathy and systolic anterior motion?
Case Report (n=3)
Does transapical transcatheter edge-to-edge repair (TA-TEER) improve left ventricular outflow tract gradients and mitral regurgitation in patients with obstructive hypertrophic cardiomyopathy and systolic anterior motion?
Transapical transcatheter edge-to-edge repair may offer a viable salvage option for highly selected patients with obstructive hypertrophic cardiomyopathy and SAM-predominant obstruction, though careful surveillance for clip displacement is essential.
May warrant evaluation as salvage option in select obstructive HCM with SAM; leaves open durability and safety in larger cohorts.
Transapical mitral valve edge-to-edge repair (TA-TEER) offers a therapeutic option for obstructive hypertrophic cardiomyopathy with severe mitral regurgitation and systolic anterior motion. In this case series, we present 3 elderly patients with obstructive hypertrophic cardiomyopathy who underwent TA-TEER after declining conventional surgical options. Patient 1: A 66-year-old woman achieved immediate resolution of mitral regurgitation and systolic anterior motion, but developed hemolysis and hypotension at 2 weeks, requiring mechanical valve replacement. Patient 2: A 65-year-old man showed sustained improvement with resolved mitral regurgitation and systolic anterior motion at 4-month follow-up. Patient 3: A 70-year-old woman demonstrated immediate resolution with stable results. TA-TEER successfully addressed mitral regurgitation and systolic anterior motion in all cases, though 1 patient experienced serious complications requiring reoperation. Although TA-TEER may serve as a salvage option for high-risk patients, careful patient selection and awareness of potential complications are essential.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) conducted a case report in Obstructive hypertrophic cardiomyopathy with severe mitral regurgitation and systolic anterior motion (n=3). Transapical mitral valve edge-to-edge repair (TA-TEER) was evaluated on Resolution of mitral regurgitation and systolic anterior motion with reduction of left ventricular outflow tract gradient. Transapical edge-to-edge repair resolved systolic anterior motion and reduced mean LVOT gradient from 108.0 to 18.0 mm Hg in 3 patients, though 1 required reoperation for clip displacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: